KENDRA POARCH
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry HIGHLANDS RANCH, CO NPI 1013668607
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry CO Otsuka America Pharmaceutical, Inc. All categories
General Payments — all program years on this page
$940.26
- Category: General Payments
- Program years: PY2022–2024
- Record count: 48
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $144.72 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $144.72 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $35.76 | 2 |
| Alkermes, Inc. | $23.54 | 1 |
| Neurocrine BioSciences, Inc. | $21.62 | 1 |
| ABBVIE INC. | $17.55 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $17.04 | 1 |
| Supernus Pharmaceuticals, Inc. | $14.94 | 1 |
| Vanda Pharmaceuticals Inc. | $14.27 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1113846274 | ABBVIE INC. | $17.55 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119164084 | Otsuka America Pharmaceutical, Inc. | $18.36 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119164086 | Otsuka America Pharmaceutical, Inc. | $17.40 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1120574559 | Alkermes, Inc. | $23.54 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133964545 | Vanda Pharmaceuticals Inc. | $14.27 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1146788585 | IDORSIA PHARMACEUTICALS US INC | $17.04 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147892922 | Supernus Pharmaceuticals, Inc. | $14.94 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150971709 | Neurocrine Biosciences, Inc. | $21.62 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.